Results 191 to 200 of about 16,771 (215)

Complications in a Patient With Multiple Myeloma Mimicking Bronchopneumonia. [PDF]

Cureus
Gowda A, Guruswamy P, Shyllesh H A, Kumar TN.   +3 more
europepmc   +1 more source

Increased IGF2 and Immunosuppressive Cell Populations in Ascites of Patients with Recurrent High-Grade Serous Ovarian Cancer. [PDF]

Biomedicines
Mortan LF, Bohn JA, Benbrook DM.
europepmc   +1 more source

High pretreatment peripheral blood T‐cell receptor clonality as a predictor of prolonged response in immune thrombocytopenia to the British Journal of Haematology

British Journal of Haematology, EarlyView.
Left panel: Scheme of the XPAG‐immune thrombocytopenia trial. The dexamethasone (DEX) arm consisted of DEX 40 mg/day for days 1–4 for one to three cycles every 28 days to a maximum of 12 weeks, cycles 2 + 3 were optional. Patients randomised to eltrombopag (ETB) + DEX received eltrombopag in combination with a short course of high‐dose DEX beginning on
Paul Schmidt‐Barbo, Christoph Schultheiss, Annaïse J. Jauch, Donjetë Simnica, Gerda Silling, Mathias Hänel, Jörg Chromik, Thomas Stauch, Karolin Trautmann‐Grill, Roland Repp, Clemens Schulte, Bastian Fleischmann, Manfred Welslau, Martina Stauch, Claudia Quiering, Frank Richter, Tamara Tesanovic, Sabine Jahn, Andreas Holbro, Jakob R. Passweg, Axel Matzdorff, Mathias Rummel, Oliver Meyer, Falk Nimmerjahn, Mascha Binder   +24 more
wiley   +1 more source

Low IgE and absence of sensitization in non-T2 asthma: a transcriptomic and cytokine study. [PDF]

Front Immunol
Lee JH, Lin YT, Wang LC, Yu HH, Hu YC, Yang YH, Chiang BL.   +6 more
europepmc   +1 more source

Protein tyrosine phosphatases as emerging targets for cancer immunotherapy

British Journal of Pharmacology, EarlyView.
Abstract Contemporary strategies in cancer immunotherapy, despite remarkable success, remain constrained by inherent limitations such as suboptimal patient responses, the emergence of drug resistance, and the manifestation of pronounced adverse effects. Consequently, the need for alternative strategies for immunotherapy becomes clear.
Zihan Qu, Jiajun Dong, Zhong‐Yin Zhang
wiley   +1 more source

Analysis of CDR3 region diversity with different lengths in bovine immunoglobulin heavy chain genes. [PDF]

Front Immunol
Zhao H, Tang X, Zhang Y, Wu M.
europepmc   +1 more source

Novel approaches for drug development against chronic primary pain: A systematic review

British Journal of Pharmacology, EarlyView.
Abstract Chronic primary pain (CPP) persisting for more than 3 months, associated with significant emotional distress without any known underlying cause, is an unmet medical need. Traditional or adjuvant analgesics do not provide satisfactory pain relief for a great proportion of these patients.
Valéria Tékus, Éva Borbély, Andreas Goebel, Ralf Baron, Zsófia Hajna, Zsuzsanna Helyes   +5 more
wiley   +1 more source

Development of a humanized anti-fibrin monoclonal antibody for the treatment of neuroinflammatory and retinal diseases. [PDF]

J Neuroinflammation
Kantor AB, Rickert M, Cheng H, Flanagan K, Salgotra V, Suppahia A, Ryu JK, Widboom PF, Warfield JR, Akassoglou K, Stavenhagen JB.   +10 more
europepmc   +1 more source

Sex-specific transcriptional regulation in lung macrophages during sub-acute <i>Mycobacterium tuberculosis</i> infection. [PDF]

Microbiol Spectr
Dhanyalayam D, Thangavel H, Lizardo K, Desai JV, Nagajyothi JF.   +4 more
europepmc   +1 more source

Isolation of purified H and L polypeptide chains from guinea-pig gamma-2-immunoglobulin after mild reduction.

, 1966
Michael E. Lamm, Victor Nussenzweig, Baruj Benacerraf   +2 more
openalex   +1 more source